Author Contributions Acquisition, analysis, or interpretation of data: Hammad Khan, Shahab Khan, Khizer Hamza, Faiza Gul, Sana Atta Ullah Drafting of the manuscript: Hammad Khan, Azra Jabin, Zain Ullah Durrani, Faiza Gul, Sana Atta Ullah, Saleem Shah Supervision: Hammad Khan Concept and design: Azra Jabin, Zain Ullah Durrani, Fahad Dayam, Muhammad Yaseen, Saleem Shah Critical review of the manuscript for important intellectual content: Shahab Khan, Khizer Hamza, Fahad Dayam, Muhammad Yaseen, Saleem Shah References 1.Glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists in the treatment of obesity/metabolic syndrome, prediabetes/diabetes and non-alcoholic fatty liver diseasecurrent evidence
2020;217(4): e20190062
All four programs confirm eligibility by state during intake, before you pay
How accurate are pregnancy tests
Does Cannabis Affect Wegovy Weight Loss Results
What is Dumping Syndrome